prevalence of risk factors was obtained from all patients. Detailed clinical history and physical examination was done. Venous blood sample was collected for NT pro BNP before starting fibrinolytic therapy. NT pro BNP was determined by sandwich immunoassay on an Elecsys 1010 (Roche Diagnostics).Additional clinical data was recorded include a detailed description of complications encountered during hospital stay such as ventricular arrhythmia, complete heart block, cardiac failure, cardiogenic shock, other complications of STEMI and death.
Statistical Analysis:
Statistical analyses were carried out by using the Statistical Package for Social Sciences version 20.0 for Windows (SPSS Inc., Chicago, Illinois, USA). A descriptive analysis was performed for all data. The quantitative and qualitative observations were indicated by frequencies and percentages. Chi-Square test was used to analyze the categorical variables was shown with cross tabulation and unpaired t-test was used to analyze the continuous variable was expressed as mean (±SD). Receiver operating characteristic (ROC) curves was generated to determine the cutoff values for the best sensitivity, specificity for prediction of mortality and complication. A P-value will considered to be statistically significant if <0.05.
Results and observations:
A total number 115 patients with STEMI, out of them 93 patients were male and male to female ratio was 4.2:1. Majority 52(45.2%) patients were in 5 th decade. Mean age was found 58.7±11.0 years in adverse outcome group and 50.04±8.9 years in no adverse outcome group. There were statistically significant (p<0.05) between two groups except result of smoking and Diabetes mellitus which was not statistically significant (p>0.05) between two groups (Table-1).Regarding in hospital outcome, patient with adverse outcome group had high N-terminal pro BNP level than no adverse outcome group (Table-2 ). Based on the receiver-operator characteristic (ROC) curves in this series it was observed that N-Terminal Pro BNP level had area under curve 1.000, which gave a cut off value e"480.0 pg/ ml, with 88.5% sensitivity and 100.0% specificity for prediction of complications. Similarly based on the receiver-operator characteristic (ROC) curves N-Terminal Pro BNP level had area under curve 0.963, which gave a cut off value >725 pg/ml, with 72.7% sensitivity and 93.3% specificity for prediction of mortality. Table I shows association of characteristics and outcome of the patients. Mean age was found 58.7±11.0 years in adverse outcome group. All other result was statistically significant (p<0.05) between two groups except result of smoking and Diabetes mellitus which was not statistically significant (p>0.05). Table II shows association of hospital outcome with Nterminal pro BNP level. It was observed that patient with adverse outcome group had high N-terminal pro BNP level than no adverse outcome group.
Discussion:
In this present series it was observed that out of one hundred fifteen patients 32.2% patient had adverse outcome among them 9.6% patients died, heart failure 13.0%, cardiogenic shock 7.8%, VT & VF 5.2%, acute MR 2.6%, VSR 0.9%, CHB 2.6% and 67.8% patient had no adverse outcome. Galvani et al. (2004) mentioned in their report that out of one hundred thirteen patients 6.4% died within 30 days. 3 In another study Ezekowitz et al. (2006) found 6.0% deaths, 6.3% with cardiogenic shock, 0.3% stroke and 6.6% with new-onset heart failure. In our study mortality was a bit more than other relevant study. 4 According to association between hospital outcomes with N-terminal pro BNP level, it was observed in this present series that the mean N-terminal pro BNP level was higher in adverse outcome group. Similarly patients who had an event had a significantly higher median NT-pro BNP compared with those who remained event-free (P<0.05) reported by previous several authors such as Galvani [3] [4] [5] [6] The mechanisms potentially responsible for the strong association between NT-pro BNP elevations and shortterm mortality cannot be ascertained by the present study. However, BNP and NT-pro BNP release may be triggered by transient or permanent ventricular dysfunction induced by myocardial ischemia. 7 Moreover, the magnitude of the increase may reflect the extent of the ischemic injury, elevations being detected soon after the onset of myocardial ischemia. [8] [9] We measured NT-pro BNP after the onset of ischemic symptoms. Such early increases may reflect the amount of the ischemic insult to the myocardium rather than the of actual extent myocardial necrosis. Accordingly the prognostic accuracy of NT-pro BNP was suggesting that NT-pro BNP may be considered as an early ischemic marker.
In this present study it was observed that based on the receiver-operator characteristic (ROC) curves N-Terminal Pro BNP level had area under curve 0.963, which gave a cut off value >725 pg/ml, with 72.7% sensitivity and 93.3% specificity for prediction of mortality. Similarly, Based on the receiver-operator characteristic (ROC) curves in this series it was observed that N-Terminal Pro BNP level had area under curve 1.000, which gave a cut off value >480.0 pg/ml, with 88.5% sensitivity and 100.0% specificity for prediction of complications. Michael Weber et al. (2008) obtained in their study that receiver-operating characteristics curve analysis yielded an optimal cutoff value of 474 pg/ml for NT-pro BNP that was able to discriminate patients at higher risk. 6 In receiver operating characteristic analysis Bjorklund et al. (2006) showed NT pro BNP strongly associated with mortality(area under the curve 0.81, 95% confidence interval (CI) 0.72 to 0.9, 0.67, 95% CI 0.56 to 0.79, and 0.66, 95% CI 0.56 to 0.77, respectively), which is closely resembled with the present study. 5 The present study is the first one to demonstrate that a single measurement of NT-pro BNP, obtained on admission, provides important prognostic information of STEMI patients. In this study, we have demonstrated that the early measurement of NT-pro BNP provides important information for risk stratification of STEMI. To the best of our knowledge, this is the first time that elevations of NTpro BNP early after symptom onset are shown to have a profound and independent impact on short-term mortality in STEMI patients. Such findings may have important implications for immediate management of high-risk patients with STEMI. Our results, obtained at the earliest time from symptom onset. In particular, they confirm the prognostic value of natriuretic peptides even in patients without heart failure as detected by patient history or at initial evaluation.
Conclusion:
N-Terminal Pro BNP level was highly sensitive and very much effective in the evaluation of adverse outcome of fibrinolytic treated ST elevation myocardial infarction (STEMI).We have demonstrated that higher N-Terminal Pro BNP level is associated with not only higher complication but also mortality in STEMI patients. So it can be concluded that N-Terminal Pro BNP level is a useful prognostic value to detect the hospital outcome of ST elevation myocardial infarction (STEMI) patients.
Limitations:
Although the result of this study supports the hypothesis there are some facts to be considered which might affect 
